✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous
Market Cap
₹6 Cr.
P/E
0.00
About
Brawn Biotech Ltd is involved in the manufacture of tablets, capsules, and oral syrups,contract manufacture, and supply of pharmaceutical products. The company's products are made under various categ… Read more
Brawn Biotech Ltd is involved in the manufacture of tablets, capsules, and oral syrups,contra… Read more
Low
15
52W Range
High
28
  • Brawn Biotech
  • Simplex Papers
  • Worldwide Aluminium

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Brawn Biotech Ltd. Business

Brawn Biotech Ltd is a pharmaceutical company engaged in manufacturing tablets, capsules, and oral syrups across various categories including Analgesics, Antibiotics, and Cardiovascular drugs.

Brawn Biotech major competitors are PM Telelinks, PAE, Lexoraa Industries, Aviva Inds, Centron Indl. Allian, Ashiana Agro, Voltaire Leasing.
Market Cap of Brawn Biotech is ₹6 Crs.
While the median market cap of its peers are ₹5 Crs.

Brawn Biotech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material